A Critical Analysis Of China’s Health Reform
This article was originally published in PharmAsia News
2008 will see the introduction of China's new health reform and policies. This editorial gives an overview of the woes plaguing the health care system such as low medical manpower and resources versus high user demand, poor medical facilities and distribution networks in rural areas, and escalating personal expenses. Also highlighted are adverse policies and a lack of proper standards for medical administration, private hospitals, retail market, health insurance schemes, and inconsistent controls that challenge the whole medical infrastructure. A summary of the previous health care system's adjustments and proposed drafts since the start of China's reform is provided to show the government's attempts to address these pressing issues. (Click here for more)
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.